Digital image analysis allows objective stratification of patients with silent PIT1 ‐lineage pituitary neuroendocrine tumors
The Journal of Pathology: Clinical Research · 2023-11 · 9 (6) · 488-497
DOI: 10.1002/cjp2.340 ↗At a glance
Journal article in The Journal of Pathology: Clinical Research, published online on 2023-09-04. Written by Jiangyan Zhao and 16 co-authors. Institution: Department of Neurosurgery, Huashan Hospital, Institutes of Biomedical Sciences, Fudan University, Shanghai, PR China. Major MEDLINE topics: Pituitary Neoplasms, Transcription Factor Pit-1, Neuroendocrine Tumors, Biomarkers, Tumor. Cited 8 times so far (Crossref); 20 references. The full text is freely available (open access, CC BY 4.0). Funded by: CAMS Innovation Fund for Medical Sciences, National Natural Science Foundation of China.
Abstract (original language)
Studies describing the clinical presentation and prognosis of patients with silent PIT1 (pituitary specific transcription factor)‐lineage pituitary neuroendocrine tumors (PitNETs) are rare. We identified patients with positive PIT1 tumor staining but without evidence of hormone hypersecretion at a tertiary center. Clusters were obtained according to cell morphology and immunostaining from each patient's digitally segmented whole slide image. We compared the clinical presentations, radiological features, and prognoses of the different clusters. We identified 146 patients (68 male, 42.9 ± 14.1 years old) with silent PIT1‐lineage PitNETs. Morphology clustering suggested that tumors with large nuclei and apparent eccentricity were associated with a higher proportion of aggressiveness and a higher hazard of recurrence [hazard ratio (HR): 2.64, (95% CI, 1.06–6.55), p = 0.037]. Immunohistochemical clustering suggested that tumors with thyroid stimulating hormone (TSH) staining or all negative PIT1‐lineage hormones were associated with a higher proportion of aggressiveness and a higher risk of recurrence [HR: 12.4, (95% CI, 1.60–93.5), p = 0.015]. We obtained three‐tier risk profiles by combining morphological and immunohistochemical clustering. Patients with the high‐risk profile presented the highest recurrence rate compared with those in the medium‐risk and low‐risk profiles [HR: 3.54, (95% CI, 1.40–8.93), p = 0.002]. In conclusion, digital image analysis based on cell morphology and immunohistochemical staining allows objective stratification of patients with silent PIT1‐lineage tumors. Typical morphological characteristics of high‐risk tumors are large tumor nuclei and high eccentricity, and typical immunostaining characteristics are TSH staining or negative staining for all PIT1‐lineage hormones.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Neurosurgery, Huashan Hospital, Institutes of Biomedical Sciences, Fudan University, Shanghai, PR China.
- National Center for Neurological Disorders, Shanghai, PR China.
- Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, PR China.
- Neurosurgical Institute of Fudan University, Shanghai, PR China.
- Shanghai Clinical Medical Center of Neurosurgery, Shanghai, PR China.
- Department of Pathology, Huashan Hospital, Shanghai, PR China.
ORCID profiles: Nidan Qiao
Funding
- CAMS Innovation Fund for Medical Sciences
- National Natural Science Foundation of China
Cite
APA
Zhao, J., Ji, C., Cheng, H., Ye, Z., Yao, B., Shen, M., Shou, X., Zhou, X., Ye, H., Zhang, Z., Chen, H., Wang, Y., He, F., Zhao, Y., Gong, W., Zhang, Q., & Qiao, N. (2023). Digital image analysis allows objective stratification of patients with silent PIT1 ‐lineage pituitary neuroendocrine tumors. The Journal of Pathology: Clinical Research, 9(6), 488-497. https://doi.org/10.1002/cjp2.340
Vancouver
Zhao J, Ji C, Cheng H, Ye Z, Yao B, Shen M, et al. Digital image analysis allows objective stratification of patients with silent PIT1 ‐lineage pituitary neuroendocrine tumors. The Journal of Pathology: Clinical Research. 2023;9(6):488-497. doi:10.1002/cjp2.340
BibTeX
@article{Zhao2023,
author = {Zhao, Jiangyan and Ji, Chenxing and Cheng, Haixia and Ye, Zhen and Yao, Boyuan and Shen, Ming and Shou, Xuefei and Zhou, Xiang and Ye, Hongying and Zhang, Zhaoyun and Chen, Hong and Wang, Yongfei and He, Fuchu and Zhao, Yao and Gong, Wei and Zhang, Qilin and Qiao, Nidan},
title = {Digital image analysis allows objective stratification of patients with silent PIT1 ‐lineage pituitary neuroendocrine tumors},
journal = {The Journal of Pathology: Clinical Research},
year = {2023},
volume = {9},
number = {6},
pages = {488--497},
doi = {10.1002/cjp2.340}
}
EUVIMED